| Literature DB >> 31264023 |
Guangcai Ren1,2, Han Wang3, Miaorong Huang1, Yuanyuan Yan3, Fan Liu3, Ruiai Chen4,5,6.
Abstract
Fowl adenovirus serotype 4 (FAdV-4) is a causative agent of inclusion body hepatitis and hydropericardium-hepatitis syndrome. These diseases cause considerable economic losses in the global poultry industry and are significant stressors for infected chickens. However, the molecular mechanisms of FAdV-4 pathogenesis are poorly understood. In the present study, we identified differentially expressed genes from the livers of FAdV-4-infected chickens using RNA-seq at 7, 14 and 21 days after FAdV-4 infection. We identified 2395 differentially expressed genes at the three time points. These genes were enriched in variety of biological processes and pathways including PPAR and Notch signaling, cytokine-cytokine receptor interactions and Toll-like receptor signaling pathways. The transcriptional data were validated by quantitative real-time PCR. Our results will assist in the understanding of the molecular pathogenesis of FAdV-4 infection and for developing novel antiviral therapies.Entities:
Keywords: Differentially expressed genes; Fowl adenovirus serotype 4; Hydropericardium–hepatitis syndrome; Molecular pathogenesis; RNA-seq
Mesh:
Year: 2019 PMID: 31264023 PMCID: PMC6746880 DOI: 10.1007/s11262-019-01676-w
Source DB: PubMed Journal: Virus Genes ISSN: 0920-8569 Impact factor: 2.332
Fig. 1Pathologic examination of livers infected with the FAdV-4 GX-1 strain on day 7 post-infection. a Gross lesions in liver. c Hematoxylin–eosin staining in liver. Solid arrows indicate viral inclusion bodies e immunohistochemical analysis of liver. b, d, f Negative controls
Fig. 2PCR analysis of viral DNA from infected livers. Agarose gel electrophoresis of PCR amplicons visualized by EtBr staining and UV light. Lane M: DL 2000 bp marker, lane 1–3: viruses DNA in the liver sample at 7 dpi, lane 4–6: viruses DNA in the liver sample at 14 dpi, lane 7–9: viruses DNA in the liver sample at 21 dpi, lane 10: negative control, lane 11: positive control
Fig. 3Identification of differentially expressed genes. a Numbers of differentially expressed genes. b Venn diagram of differentially expressed genes during the course of infection
Fig. 4Clusters of differentially expressed genes and numbers of differentially expressed genes in different clusters. Numbers indicated profiles or gene numbers. Significantly different profiles were represented by different background colors
Fig. 5Top 10 GO categories significantly enriched in biological process at 7, 14, and 21 dpi
Fig. 6KEGG pathways significantly enriched in biological process at 7, 14, and 21 dpi
KEGG pathways related to lipid metabolism signal pathway and immune response at three time points
| Pathway ID | KEGG pathway | 7 dpi | 14 dpi | 21 dpi | |||
|---|---|---|---|---|---|---|---|
| Upregulated genes | Downregulated genes | Upregulated genes | Downregulated genes | Upregulated genes | Downregulated genes | ||
| ko03320 | PPAR signaling pathway | PCK1, ACAA1, ACOX1,EHHADH, CPT1A, ACSL1, FABP1, FABP2 | ACSBG2, MMP-1, GK | FABP3, PCK1, FABP1, FABP2, MMP1 | ANGPTL4 | FABP3, PLIN2, PPARG, SCD, ANGPTL4 | GK |
| ko04010 | MAPK signaling pathway | STMN1, RPS6KA5 | FLNA, FGF1, TGFB3, DUSP4, FOS, JUN, HSPA2 | MAP3K8 | HSPA2 | PRKACB, DUSP8, PDGFRA, FGF23, RAP1A, FAS, RASA2, AKT1, RPS6KA2, IL1R1, DUSP4, RPS6KA5, MAP3K1, PLA2G4A | CACNA1D, FOS |
| ko04060 | Cytokine–cytokine receptor interaction | TNFSF15, KIT | IFN-A, IL18, TGFB3, TNFRSF13B | IL22RA2, IFN-A, CSF3R | CCL19, CCL20, IFN-A, IL18, PDGFRA, INHBB, CX3CL1, OSMR, IL6ST, IFNG, LIFR, CCR6, IL1R1, FAS, IL22RA1, KIT, IL21R, CSF2RA, CCR5 | IFN-A | |
| ko04068 | FoxO signaling pathway | PLK4, PCK1, PLK1, CCNB2 | TGFB3, CDKN1A, INS, p15 | PCK1,CDKN1A, G6PC2 | CCND2, PI3 K, PLK4, PTEN, AKT1, CDKN2B, CCNG2, FBXO25, PLK3, PRKAA2, CDKN1A, G6PC2 | ||
| ko04115 | p53 signaling pathway | CDK1, RRM2, GTSE1, CCNB2 | CDKN1A | CDKN1A | CCND2, PTEN, FAS, APAF1, ATR, CCNG2, GTSE1, CDKN1A, SESN1 | ||
| ko04310 | Wnt signaling pathway | WNT6, JUN, Wnt10a | WNT11 | CCND2, Chd8, PRKACB, NFATC2, MMP7 | |||
| ko04330 | Notch signaling pathway | RBPJL, EP300 | HES1, CREBBP | DTX3L, CREBBP | |||
| ko04350 | TGF-beta signaling pathway | TGFB3, CDKN2B | PPP2R1A | INHBB, IFNG, CDKN2B | |||
| ko04620 | Toll-like receptor signaling pathway | IFN-A, FOS, JUN | IFN-A, MAP3K8 | TLR1, TLR2, STAT1, TLR7, IFN-A, NFKBIA, AKT1, CD86, TLR4, PI3 K | IFN-A, FOS | ||
| ko04621 | NOD-like receptor signaling pathway | CATHL2 | IFN-A, IL18, JUN | IFN-A | STAT1, IFN-A, IL18, ATG5, PRKCD, CARD9, NFKBIA, ITPR3, P2RX7, CYBB, NAMPT, IFN-A, TLR4 | IFN-A | |
| ko04622 | RIG-I-like receptor signaling pathway | IFN-A | IFN-A | IFN-A, ATG5, NFKBIA, MAP3K1, TRIM25, DHX58 | IFN-A | ||
| ko04623 | Cytosolic DNA-sensing pathway | IFN-A, IL18 | IFN-A | IFN-A, IL18, NFKBIA | IFN-A | ||
| ko04630 | Jak-STAT signaling pathway | PTPN2 | IL22RA2, PTPN2 | PTPN2 | CCND2, PTPN2 | ||
| ko04672 | Intestinal immune network for IgA production | PIGR | TNFRSF13B | BLB1 | LICOS, ICOS, AICDA, CD86 | ||
Fig. 7Comparison of expression levels of seven genes obtained by RNA-seq analysis (a) and by RT-PCR (b)